Home » Newsletters » BioWorld Asia

BioWorld Asia

March 10, 1999

View Archived Issues

Amrad Sells Baxter Rights To Heart Protein For $22M

NeuroSearch, P&U Ending Deal On Anxiety Treatment

On-The-Spot Tests Could Let Physicians Identify Genotype, Determine Strongest Treatment

Oxford Ends Year Strong; Deals Fuel Cash Position

Inpharmatica Raises #3M In Second Financing Round

RPR Joins Genetics Institute Roster Of Database Buyers

Axis, Roche Join Forces To Test Animal Vaccines

Chiroscience Regains Rights To Lead Anesthetic Product

Actinova In Three-Way Pact For Streptococcus Vaccine

Oxford BioMedica Raising #3.6M For Cancer Study

SR Pharma, Corixa Enter Second Licensing Deal

Stocks Follow Biota Slide After Flu Drugs Refusal

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.